2021
DOI: 10.1007/s00210-020-02039-1
|View full text |Cite
|
Sign up to set email alerts
|

Can MitoTEMPO protect rat sciatic nerve against ischemia-reperfusion injury?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…Tempo (4‐hydroxy‐2,2,6,6‐tetramethylpiperidine‐1‐oxyl) is a cell‐permeable synthetic cyclic nitroxide compound that reduces the intracellular ROS, subsequently protect the cells and tissues from oxidative injuries 31 . Mito‐TEMPO is a modified form of Tempo with triphenylphosphonium that directly targets mitochondria 32 . EUK‐134 and EUK‐8 are salen Mn, synthetic superoxide dismutase (SOD)/catalase mimetics that have beneficial effects in many models of oxidative stress is an antioxidant with powerful SOD, catalase and oxyradical scavenging property 33 (Figure 1A,a–d).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Tempo (4‐hydroxy‐2,2,6,6‐tetramethylpiperidine‐1‐oxyl) is a cell‐permeable synthetic cyclic nitroxide compound that reduces the intracellular ROS, subsequently protect the cells and tissues from oxidative injuries 31 . Mito‐TEMPO is a modified form of Tempo with triphenylphosphonium that directly targets mitochondria 32 . EUK‐134 and EUK‐8 are salen Mn, synthetic superoxide dismutase (SOD)/catalase mimetics that have beneficial effects in many models of oxidative stress is an antioxidant with powerful SOD, catalase and oxyradical scavenging property 33 (Figure 1A,a–d).…”
Section: Resultsmentioning
confidence: 99%
“…31 Mito-TEMPO is a modified form of Tempo with triphenylphosphonium that directly targets mitochondria. 32 EUK-134 and EUK-8 are F I G U R E 2 Molecular docking studies between HSF-, NN-PLA 2 with EUK-8: Energetically favorable binding modes of EUK-8 was calculated using induced fit molecular docking method. The hydrogen bonding and hydrophobic interactions between the EUK-8 with HSF-PLA 2 and NN-PLA 2 are depicted using the LigPlot software.…”
Section: Discussionmentioning
confidence: 99%
“…There are studies from other research groups in various pathologies, as well as from our laboratory in ischemia-reperfusion injury, demonstrating therapeutic and/or protective effects of MitoTEMPO when applied at a dose of 0.7 mg/kg/day [28][29][30][31]. Therefore, this dose has been chosen in the current study.…”
Section: Nerve Dissection and Experimental Setupmentioning
confidence: 99%
“…In addition, SS31 accumulates in the mitochondrial membrane to protect and restore the mitochondrial structure without affecting healthy mitochondria (162,(447)(448)(449)(450)(451)(452)(453). Thus, SS31 and mitoTEMPO have protective effects on a variety of diseases, including heart and kidney-related diseases, as well as sepsis and diabetes, which have been demonstrated in a variety of animal models (454)(455)(456)(457). The use of nanomaterials for mitochondrial targeting therapy has become a recent focus of research.…”
Section: Mitochondrialmentioning
confidence: 99%